Carsten Schroeder

Carsten Schroeder joined MicroVention as President and CEO in November of 2020. Mr. Schroeder has more than 25 years of senior executive experience across pharmaceuticals, medical devices, and in-vitro diagnostics. Prior to MicroVention, he was President and CEO of Grifols Diagnostic Solutions, (joining Grifols through the acquisition of Novartis Diagnostics). He was the also the President of the Diagnostic Business Unit and the Site Head for Novartis in Emeryville, CA. Before Novartis, he held various Vice President positions at Boston Scientific for nine years and was based in France, Germany, and the United States. During this time, he was responsible for the neurovascular business. Mr. Schroeder speaks several languages and has lived in over 10 countries throughout his career.

Mr. Schroeder earned his Bachelor of Arts in Economics from the University of Cologne in Germany and a Master of Business from the European School of Management in Paris (ESCP).